Overview

Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One Patient

Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
This is an open-label, long term compassionate use study of 125 mg per day of azimilide 2HCl in a patient who completed two other protocols (2000098 and 2001060.
Phase:
Phase 2
Details
Lead Sponsor:
Forest Laboratories
Warner Chilcott
Treatments:
Azimilide